| |
The purpose of and scope of this report
- To be an essential resource for diagnostics and biotechnology companies aiming to understand and access China's molecular diagnostics market
- To provide a primary point for investors, entrepreneurs and potential acquirers of China diagnostic kit, reagent, and equipment manufacturers
- This report provides an overview and fundamental analysis of China's molecular diagnostics industry and its application and major players. Includes:
- The history of China molecular diagnostics
- The main molecular diagnostics technologies used in China and related products including PCR, qPCR, nucleic acid extraction, and biochip technologies
- Policy explanations and changes
- Key manufacturers and sales strategies
- 4 case studies
- Key points and guidance for important regulations
- Domestic and MNC kits and devices approved by SFDA and their indications, including over 75 PCR kits, cyclers, and systems as well as 25 biochip kits and instruments
- SFDA approved human gene markers and indications
- Market trends and forecasts
Who would benefit from this report?
- Executives and marketing directors and managers of:
- Molecular diagnostics manufacturers
- Other diagnostics manufacturers
- Biotechnology companies
- Investors
- Venture capitalists
- Entrepreneurs
- Others who require information concerning molecular diagnostics in China
Why is this report unique?
- The author has more than five years experience in molecular diagnostics sales in China
- Very few reports on the molecular diagnostics industry in China currently exist
Methodology
- Discussions with professionals at:
- Molecular diagnostics manufacturers
- Molecular diagnostics distributors
- End-users
|
|